Latest Atheroma Stories
LOS ANGELES, Oct. 5 /PRNewswire/ -- According to a clinical study released in The American Journal of Cardiology, a daily serving of POM Wonderful 100% Pomegranate Juice may decrease the progression of arterial plaque in patients with elevated cardiovascular disease risk factors.
U.S. doctors say the untreated plaques causing unexpected heart attacks are not mild lesions as previously thought. The plaques are made up of fat, cholesterol, calcium and other substances found in the blood.
Late-breaking results from the PROSPECT clinical trial shed new light on the types of vulnerable plaque that are most likely to cause sudden, unexpected adverse cardiac events, and on the ability to identify them through imaging techniques before they occur.
SAN FRANCISCO, Sept.
SAN FRANCISCO, Sept. 24 /PRNewswire-FirstCall/ -- Abbott (NYSE: ABT) today announced primary results from its groundbreaking PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) clinical trial.
SAN FRANCISCO, Sept.
A new trial has begun in order to ascertain once and for all whether the best strategy for patients who cannot receive P-PCI is early fibrinolysis, together with mandated angiography.
DOYLESTOWN, Pa., Aug. 24 /PRNewswire/ -- Medical device pioneer, Prescient Medical, Inc., announced today that it has received European CE Mark (Conformite Europeene) approval to commercialize its vProtect(TM) Luminal Shield Stent System.
DOYLESTOWN, Pa., July 27 /PRNewswire/ -- Prescient Medical, Inc. has received the prestigious 2009 North American Product Innovation of the Year Award from Frost & Sullivan for Atherosclerosis Lesion Management.
The blood-thinning drug Effient has been approved to reduce the risk of blood clots in angioplasty patients, U.S. health officials say. The U.S. Food and Drug Administration approved the tablets Friday, a release from the agency indicated. The drug is made by U.S. manufacturer Eli Lilly and Co.
- A person in a secondary role, specifically the second most important character (after the protagonist).